Form 4 Filing: Hopkinson Craig C. Sells $560K of $ALKS

INSIDER SALE

⚡ MATERIALITY: 6/10

corporate issuer

Alkermes plc.

Ticker: $ALKS

Transaction Value

$560K

Price/Share: $40.02

transaction date

2026-07-01

Shares: 14,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hopkinson Craig C., holds the title of EVP R&D, Chief Medical Officer at Alkermes plc..

On 2026-07-01, the insider transacted 14,000 shares.The shares were transacted at a weighted average price of $40.02 per share, resulting in a total market-relevant value of $560K.

Executive Summary Summary

Hopkinson Craig C. (EVP R&D, Chief Medical Officer) sold $560K of $ALKS

Post-Transaction Position: 74,089 shares

SEC Accession No: 0001520262-26-000103 (CIK: 1730048)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$ALKS Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$ALKS News Coverage